Tilman S.A.: Clinical Trials

5 trials sponsored by Tilman S.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 3 Not applicable, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 3
Early Phase 11Completed 1

Follow Tilman S.A.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect and Tolerance of Standardized Exclusive Dry Extracts of Curcuma Longa and of Boswellia Serrata Among People With Hand Joint Discomfort and Dysfunction
Flexofytol Forte, Placebo - Hand Joint Discomfort, Hand Joint Dysfunction
Not applicableCompletedTilman S.A.1802022-09-142025-04-08
Covid-19, Hospitalized, PatIents, Nasafytol
NASAFYTOL®, FULTIUM® -D3 800, Strandard of care treatment - Coronavirus Infection
Not applicableCompletedTilman S.A.512021-02-172022-10-13
Evaluation of Flexofytol® PLUS in Hand Joint Chronic Dyscomfort.
Flexofytol PLUS - Hand Joint Discomfort
CompletedTilman S.A.2392019-09-012023-04-12
Evaluation of FLEXOFYTOL® Versus PLACEBO
FLEXOFYTOL®, PLACEBO - Osteoarthritis
Not applicableCompletedTilman S.A.1502014-05-012017-11-06
Exploratory Non Comparative Study to Evaluate the Efficacy of Highly Bioavailable Curcumin (Flexofytol) in Patients With Knee Osteoarthritis
Flexofytol (bio-optimized curcumin) - Knee Osteoarthritis
Early Phase 1CompletedTilman S.A.222012-03-012015-06-23

Conditions studied

Osteoarthritis (2)  ·  Coronavirus Infections (1)  ·  Osteoarthritis, Knee (1)  ·  Pain (1)

Interventions

turmeric extract (1)

Countries

Belgium (5)

Top investigators

Yvan Dierckxsens (2)  ·  Caroline Castermans, MD (1)

Results publications

PMID 24886572, PMID 31351488, PMID 37426178